Zelira Therapeutics Limited (OTCMKTS:ZLDAF) Short Interest Down 50.0% in November

Zelira Therapeutics Limited (OTCMKTS:ZLDAF) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 100 shares, a drop of 50.0% from the October 31st total of 200 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is currently 0.5 days.

Zelira Therapeutics Price Performance

Shares of OTCMKTS ZLDAF remained flat at $0.45 during mid-day trading on Thursday. Zelira Therapeutics has a fifty-two week low of $0.19 and a fifty-two week high of $0.69. The company has a 50-day moving average of $0.48 and a 200 day moving average of $0.43.

Zelira Therapeutics Company Profile

Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.